by support | Aug 12, 2025 | Blogs
BRINSUPRI™ (brensocatib) Becomes First FDA-Approved Treatment for Bronchiectasis August 12, 2025 marks a new chapter in care for patients worldwide Tuesday, August 12, 2025, is a monumental day for the bronchiectasis community. The U.S. Food and Drug Administration...
by support | Jul 21, 2025 | Blogs
August 4th is World NTM Awareness Day: Shine a Light on Early Diagnosis and Patient Support Every year on August 4th, we come together to recognize World NTM Awareness Day, a global movement dedicated to raising awareness about nontuberculous mycobacterial (NTM) lung...
by support | Jul 21, 2025 | Blogs
Empowering the Patient Voice: Highlights from the 2025 NTM & Bronchiectasis Patient Conference Held May 14–15 in Berkeley, California and Online The 2025 NTM & Bronchiectasis Patient Conference brought together patients, caregivers, clinicians, and researchers...
by support | May 7, 2025 | Blogs
Supporting Mental Health for the NTM Community: Mental Health Awareness Month May is Mental Health Awareness Month, a time to shine a light on the importance of emotional well-being — especially for those living with chronic illnesses like NTM (nontuberculous...
by support | Dec 1, 2022 | Uncategorized
NTM Info & Research (NTMir) is pleased to announce the appointment of Candace Lerman, Esq. to the Board of Directors. Ms. Lerman is an attorney and author of the rare disease blog, RareCandace.com. Currently she is US Corporate Attorney at Avheris Health. She...
